Pharmaceutical Industries Ltd.
Your browser does not support iframes.
See Teva's sites around the world
Japan & S. Korea
Bosnia & Herzegovina
Want to find out more about Teva's locations and phone numbers?
Visit Teva Worldwide
Board of Directors
2015 Annual Report on Form 20-F
Over the Counter (OTC)
Central Nervous System (CNS)
Teva at IATI BIOMED 2015
Leading the Fight for Cures
National Network of Excellence
2014 Full Report
Previous CSR Reports
Global Patient Organization and Advocacy Disclosure 2015
Teva Fact Sheet
Inspiring Change for Women in Japan
PLIVA Awarded Two Golden Keys
Climbing Against MS
Webcasts and Presentations
Grow with the Best
Our Guiding Values
Grow with the Best
Go to Parent
The World's Generic Pharmaceuticals Leader
Teva aims to be the first to introduce the highest quality standards and the most competitive prices
Share on Facebook
Share on LinkedIn
A Global Powerhouse in Generic Pharmaceuticals
As the world’s leading provider of generic pharmaceuticals, Teva’s medicines help patients and consumers in a way that few other companies can.
Teva produces 73 billion tablets a year in 73 pharmaceutical and API facilities around the world. Some 2.7 million prescriptions are filled daily with Teva’s products in the EU, and an additional 1.5 million in the U.S. The scale and breadth of our generics portfolio has an unprecedented impact on global healthcare.
Teva’s exceptional integration of generics and specialty R&D enables us to generate a robust pipeline of high-value medicines, with an emphasis on complex and branded generics. Our R&D capabilities have expanded beyond tablets, capsules, liquids, ointments and creams to a broad range of effective dosage forms and delivery systems. In 2012 we launched 450 generic products.
Teva has a unique understanding of - and footprint in - world markets, where our generic medicines are tailored to the needs of local patients, physicians and consumers. We also have an unparalleled ability to partner in commercializing generic products, particularly in emerging economies.
Building on a remarkable track record of achievement, Teva continues to pursue a rich future in generics as we focus on patient needs, improving compliance, convenience, efficacy and safety, and providing affordable generic products to patients and society worldwide.
You May Also Like...
A Fresh Approach to Respiratory Care
Easing the Challenge of Pain
Teva Celebrates National Science Day in Israel